Clinical and metabolic features of the randomised controlled Diabetes Remission Clinical Trial (DiRECT) cohort

Diabetologia

Volumn 61, Issue 3, 2018, Pages 589-598

  Taylor, Roy ^a   Leslie, Wilma S ^b   Barnes, Alison C ^a   Brosnahan, Naomi ^b,c   Thom, George ^b   McCombie, Louise ^b   Sattar, Naveed ^b   Welsh, Paul ^b   Peters, Carl ^a   Zhyzhneuskaya, Sviatlana ^a   Hollingsworth, Kieren G ^a   Al Mrabeh, Ahmad ^a   Rodrigues, Angela M ^a   Rehackova, Lucia ^a   Adamson, Ashley J ^a   Sniehotta, Falko F ^a   Mathers, John C ^a   Ross, Hazel M ^c   McIlvenna, Yvonne ^b   Kean, Sharon ^b   Ford, Ian ^b   McConnachie, Alex ^b   Lean, Michael E J ^b   more..

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c Counterweight Ltd ^*  (United Kingdom)

Author keywords

Formula diet; Remission; Type 2 diabetes; Weight management

Indexed keywords

HEMOGLOBIN A1C; ANTIDIABETIC AGENT; GLYCOSYLATED HEMOGLOBIN;

ADULT; ARTICLE; BODY MASS; BODY WEIGHT; BODY WEIGHT LOSS; CLINICAL PRACTICE; COMPARATIVE STUDY; DIABETIC PATIENT; EVIDENCE BASED PRACTICE; FEMALE; GENERAL PRACTICE; HUMAN; INTENTION TO TREAT ANALYSIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; REMISSION; RURAL AREA; AGED; BLOOD; COHORT ANALYSIS; CONTROLLED STUDY; ENGLAND; GLUCOSE BLOOD LEVEL; METABOLISM; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SCOTLAND; YOUNG ADULT;

ADULT; AGED; BLOOD GLUCOSE; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; ENGLAND; FEMALE; GLYCATED HEMOGLOBIN A; HUMANS; HYPOGLYCEMIC AGENTS; MALE; MIDDLE AGED; QUALITY OF LIFE; SCOTLAND; WEIGHT LOSS; YOUNG ADULT;

EID: 85035351814     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-017-4503-0     Document Type: Article

References (26)

1. Lim EL, Hollingsworth KG, Aribisala BS, Chen MJ, Mathers JC, Taylor R (2011) Reversal of type 2 diabetes: normalisation of beta cell function in association with decreased pancreas and liver triacylglycerol. Diabetologia 54:2506–2514
2. Steven S, Lim E, Taylor R (2013) Population response to information on reversibility of type 2 diabetes. Diabet Med 30:e135–e138
3. Steven S, Hollingsworth KG, Al-Mrabeh A et al (2016) Very low calorie diet and 6 months of weight stability in type 2 diabetes: pathophysiological changes in responders and nonresponders. Diabetes Care 39:158–165
4. Guidone C, Manco M, Valera-Mora E et al (2006) Mechanisms of recovery from type 2 diabetes after malabsorptive bariatric surgery. Diabetes 55:2025–2031
5. Steven S, Carey PE, Small PK, Taylor R (2015) Reversal of type 2 diabetes after bariatric surgery is determined by the degree of achieved weight loss in both short- and long-duration diabetes. Diabet Med 32:47–53
6. Dixon J, Chuang LM, Chong K et al (2013) Predicting the glycemic response to gastric bypass surgery in patients with type 2 diabetes. Diabetes Care 36:20–26
7. McCombie L, Leslie W, Taylor R, Kennon B, Sattat N, Lean MEJ (2017) Beating diabetes with IT coding of ‘diabetes in remission’: an emerging new target for patients. BMJ 358:j4030
8. Gregg EW, Chen H, Wagenknecht LE et al (2012) Association of an intensive lifestyle intervention with remission of type 2 diabetes. JAMA 308:2489–2496
9. Lean M, Brosnahan N, McLoone P et al (2013) Feasibility and indicative results from a 12-month low-energy liquid diet treatment and maintenance programme for severe obesity. Br J Gen Pract 63:e115–e124
10. Leslie WS, Ford I, Sattar N et al (2016) The Diabetes Remission Clinical Trial (DiRECT): protocol for a cluster randomised trial. BMC Fam Pract 17:20
11. Leslie WS, Hankey CR, Lean MEJ (2007) Weight gain as an adverse effect of some commonly prescribed drugs: as systematic review. QJM 100:395–404
12. Logue J, Walker JJ, Colhoun HM et al (2011) Do men develop type 2 diabetes at lower body mass indices than women? Diabetologia 54:3003–3006
13. Ahern AL, Aveyard P, Boyland EJ, Halford JCG, Jebb SA (2016) Inequalities in the uptake of weight management interventions in a pragmatic trial: an observational study in primary care. Br J Gen Pract 66:e258–e263
14. Booth HP, Prevost AT, Gulliford MC (2015) Access to weight reduction interventions for overweight and obese patients in UK primary care: population-based cohort study. BMJ Open 5:e006642
15. Robertson C, Avenell A, Boachie C et al (2015) Should weight loss and maintenance programmes be designed differently for men? A systematic review of long-term randomised controlled trials presenting data for men and women: The ROMEO project. Obes Res Clin Pract 10:70–84
16. Hankey CR, Leslie WS, Lean MEJ (2002) Why lose weight? Reasons for seeking weight loss by overweight but otherwise healthy men. Int J Obes 26:880–882
17. De Souza P, Ciclitira E (2005) Men and dieting: a qualitative analysis. J Health Psychol 10:793–804
18. Treweek S, Lockhart, Pitkethly M et al (2013) Methods to improve recruitment to randomised controlled trials: Cochrane systematic review and meta-analysis. BMJ Open 3:e002360
19. Khunti K, Taub N, Tringham J et al (2010) Screening for the metabolic syndrome using simple anthropometric measurements in South Asian and white Europeans: a population-based screening study. The Leicester Ethnic Atherosclerosis and Diabetes Risk (LEADER) Study. Prim Care Diabetes 4:25–32
20. The LookAHEAD Research Group (2006) Baseline characteristics of the randomized cohort from the LookAHEAD (Action for Health in Diabetes) research study. Diab Vasc Dis Res 3:202–215
21. Action to Control Cardiovascular Risk in Diabetes Study Group (2008) Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 358:2545–2559
22. Dormandy JA, Charbonnel B, Eckland DJA et al (2005) Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitazone Clinical Trial in macroVascular Events): a randomised controlled trial. Lancet 366:1279–1289
23. Brierley L, McGurnaghan S, Blackbourn L, McKeigue PM, Colhoun HM (2017) The changing landscape of diabetes drug therapy in a national population of people with type 2 diabetes. Diabetologia 60(Suppl 1):A849 (Abstract)
24. Scottish Intercollegiate Guideline Network (2010) Management of diabetes: a national clinical guideline. http://www.sign.ac.uk/assets/sign116.pdf accessed 6 Nov 2017
25. National Institute for Health and Care Excellence (2015) Type 2 diabetes in adults: management https://www.nice.org.uk/guidance/ng28 accessed 6 Nov 2017
26. National Institute for Health and Care Excellence (2014) Cardiovascular disease: risk assessment and reduction, including lipid modification https://www.nice.org.uk/guidance/cg181 accessed 6 Nov 2017